Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPMC Blueprint Medicines Corporation

停牌 07-17 16:00:00 EDT

129.46

+0.00

0.00%

最高129.46	最低129.46	成交量0.00
今开129.46	昨收129.46	日振幅0.00%
总市值83.80亿	流通市值77.86亿	总股本6,473万
成交额3.85亿	换手率0.00%	流通股本6,014万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPMC","market":"US","secType":"STK","nameCN":"Blueprint Medicines Corporation","latestPrice":129.46,"timestamp":1752782400000,"preClose":129.46,"halted":3,"volume":0,"delay":0,"floatShares":60144183,"shares":64733629,"eps":-2.453242,"marketStatus":"停牌","change":0,"latestTime":"07-17 16:00:00 EDT","open":129.46,"high":129.46,"low":129.46,"amount":385046226.35985,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.453242,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1430366400000,"exchange":"NASDAQ","adjPreClose":129.46,"volumeRatio":0},"requestUrl":"/m/hq/s/BPMC","defaultTab":"news","newsList":[{"id":"2553475414","title":"赛诺菲完成对Blueprint Medicines 公司的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2553475414","media":"药事纵横","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553475414?lang=zh_cn&edition=full","pubTime":"2025-07-21 17:00","pubTimestamp":1753088400,"startTime":"0","endTime":"0","summary":"此前，赛诺菲已对外宣布，将耗资95亿美元收购Blueprint Medicines 公司，7月18日，赛诺菲对外宣布，其已完成了对Blueprint Medicines 公司的收购。Blueprint Medicines有一款已在美国和欧盟获批上市的药物Ayvakit/Ayvakyt，该产品是目前唯一获批用于治疗晚期和惰性系统性肥大细胞增多症的药物，特点是异常肥大细胞在骨髓、皮肤、胃肠道及其他器官中的积聚和活化。对Blueprint所有每股面值0.001美元的普通流通股的要约收购已于2025年7月17日（星期四）美国东部夏令时间17:00时到期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721184456a6b7d411&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721184456a6b7d411&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LU0053671581.USD","BPMC"],"gpt_icon":0},{"id":"2552453486","title":"Blueprint Medicines Corporation7月17日成交额为3.86亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552453486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552453486?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:23","pubTimestamp":1752801828,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Blueprint Medicines Corporation成交额为3.86亿美元，成交额较昨日减少88.39%，当日成交量为298.10万股。Blueprint Medicines Corporation于2025年7月17日涨0.14%，报129.46美元，该股过去5个交易日涨0.1%，年初至今涨48.43%，过去60日涨53.79%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092358a6b0d74c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092358a6b0d74c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BPMC","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2552177993","title":"Blueprint Medicines Corporation7月16日成交额为33.21亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552177993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552177993?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:23","pubTimestamp":1752715410,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，Blueprint Medicines Corporation成交额为33.21亿美元，成交额较昨日增加391.67%，当日成交量为2568.06万股。Blueprint Medicines Corporation于2025年7月16日跌0.05%，报129.28美元，该股过去5个交易日涨0.57%，年初至今涨48.22%，过去60日涨52.65%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717092341a6ae7cb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717092341a6ae7cb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2551442134","title":"Blueprint Medicines Corporation7月14日成交额为8.62亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551442134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551442134?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:24","pubTimestamp":1752542687,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，Blueprint Medicines Corporation成交额为8.62亿美元，成交额较昨日增加86.85%，当日成交量为666.89万股。Blueprint Medicines Corporation于2025年7月14日涨0.05%，报129.36美元，该股过去5个交易日涨0.75%，年初至今涨48.31%，过去60日涨58.82%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715092457a6a9d231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715092457a6a9d231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","LU0053671581.USD","BK4505"],"gpt_icon":0},{"id":"2550608237","title":"Blueprint Medicines Corporation7月10日成交额为7.74亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550608237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550608237?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:24","pubTimestamp":1752197073,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，Blueprint Medicines Corporation成交额为7.74亿美元，成交额较昨日增加101.08%，当日成交量为598.39万股。Blueprint Medicines Corporation于2025年7月10日涨0.61%，报129.33美元，该股过去5个交易日涨0.88%，年初至今涨48.28%，过去60日涨59.98%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092444a4438db5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092444a4438db5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LU0053671581.USD","BPMC"],"gpt_icon":0},{"id":"2550660473","title":"Blueprint Medicines Corporation7月9日成交额为3.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550660473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550660473?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:23","pubTimestamp":1752110610,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Blueprint Medicines Corporation成交额为3.85亿美元，成交额较昨日增加1.21%，当日成交量为299.65万股。Blueprint Medicines Corporation于2025年7月9日涨0.12%，报128.55美元，该股过去5个交易日涨0.16%，年初至今涨47.39%，过去60日涨60.15%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710092340a441590f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710092340a441590f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LU0053671581.USD","BPMC"],"gpt_icon":0},{"id":"2550577419","title":"Blueprint Medicines Corporation7月8日成交额为3.80亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550577419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550577419?lang=zh_cn&edition=full","pubTime":"2025-07-09 09:23","pubTimestamp":1752024187,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Blueprint Medicines Corporation成交额为3.80亿美元，成交额较昨日增加52.93%，当日成交量为295.92万股。Blueprint Medicines Corporation于2025年7月8日涨0.0%，报128.4美元，该股过去5个交易日涨0.17%，年初至今涨47.21%，过去60日涨56.49%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709092315a43f0a7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709092315a43f0a7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4139","BK4505","BPMC"],"gpt_icon":0},{"id":"2549056239","title":"Blueprint Medicines Corporation7月7日成交额为2.49亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549056239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549056239?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:22","pubTimestamp":1751937771,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Blueprint Medicines Corporation成交额为2.49亿美元，成交额较昨日增加43.54%，当日成交量为193.76万股。Blueprint Medicines Corporation于2025年7月7日涨0.04%，报128.4美元，该股过去5个交易日涨0.23%，年初至今涨47.21%，过去60日涨62.08%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708092301a43cce18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708092301a43cce18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LU0053671581.USD","BK4139","BPMC"],"gpt_icon":0},{"id":"2548241331","title":"Blueprint Medicines Corporation7月3日成交额为1.73亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548241331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548241331?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:23","pubTimestamp":1751592203,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Blueprint Medicines Corporation成交额为1.73亿美元，成交额较昨日减少41.77%，当日成交量为135.02万股。Blueprint Medicines Corporation于2025年7月3日涨0.12%，报128.35美元，该股过去5个交易日涨0.16%，年初至今涨47.16%，过去60日涨60.04%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092334a4ce4f28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092334a4ce4f28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4505","BK4139","BPMC"],"gpt_icon":0},{"id":"2548719832","title":"Blueprint Medicines Corporation7月1日成交额为3.33亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548719832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548719832?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:23","pubTimestamp":1751419394,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Blueprint Medicines Corporation成交额为3.33亿美元，成交额较昨日增加10.53%，当日成交量为259.48万股。Blueprint Medicines Corporation于2025年7月1日涨0.12%，报128.34美元，该股过去5个交易日涨0.06%，年初至今涨47.15%，过去60日涨47.33%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092325a4c9f012&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092325a4c9f012&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4505","BK4139","BPMC"],"gpt_icon":0},{"id":"2548433047","title":"Blueprint Medicines Corporation6月30日成交额为3.01亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548433047","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548433047?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:22","pubTimestamp":1751332945,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，Blueprint Medicines Corporation成交额为3.01亿美元，成交额较昨日减少21.36%，当日成交量为235.02万股。Blueprint Medicines Corporation于2025年6月30日涨0.05%，报128.18美元，该股过去5个交易日跌0.17%，年初至今涨46.96%，过去60日涨42.41%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092226a4c7b0f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092226a4c7b0f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BPMC","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2546877898","title":"Blueprint Medicines Corporation6月27日成交额为3.83亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546877898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546877898?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:23","pubTimestamp":1751073785,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Blueprint Medicines Corporation成交额为3.83亿美元，成交额较昨日增加18.14%，当日成交量为298.88万股。Blueprint Medicines Corporation于2025年6月27日跌0.03%，报128.11美元，该股过去5个交易日跌0.07%，年初至今涨46.88%，过去60日涨49.07%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628092311a721d71c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628092311a721d71c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4505","BPMC","BK4139"],"gpt_icon":0},{"id":"2546127635","title":"Blueprint Medicines Corporation6月25日成交额为3.14亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546127635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546127635?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:23","pubTimestamp":1750901004,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日，Blueprint Medicines Corporation成交额为3.14亿美元，成交额较昨日减少27.59%，当日成交量为244.47万股。Blueprint Medicines Corporation于2025年6月25日跌0.01%，报128.25美元，该股过去5个交易日涨0.02%，年初至今涨47.04%，过去60日涨44.56%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626092334a4be3617&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626092334a4be3617&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","LU0053671581.USD","BK4505"],"gpt_icon":0},{"id":"2546842250","title":"Blueprint Medicines Corporation6月24日成交额为4.33亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546842250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546842250?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:23","pubTimestamp":1750814581,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Blueprint Medicines Corporation成交额为4.33亿美元，成交额较昨日减少0.88%，当日成交量为337.70万股。Blueprint Medicines Corporation于2025年6月24日跌0.11%，报128.26美元，该股过去5个交易日涨0.01%，年初至今涨47.05%，过去60日涨42.94%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625092314a4bc5a0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625092314a4bc5a0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LU0053671581.USD","BK4139","BPMC"],"gpt_icon":0},{"id":"2545241674","title":"Blueprint Medicines Corporation6月23日成交额为4.37亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545241674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545241674?lang=zh_cn&edition=full","pubTime":"2025-06-24 09:22","pubTimestamp":1750728176,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日，Blueprint Medicines Corporation成交额为4.37亿美元，成交额较昨日减少24.35%，当日成交量为340.75万股。Blueprint Medicines Corporation于2025年6月23日涨0.16%，报128.4美元，该股过去5个交易日涨0.34%，年初至今涨47.21%，过去60日涨41.53%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624092302a71a41d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624092302a71a41d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LU0053671581.USD","BK4139","BPMC"],"gpt_icon":0},{"id":"2545109774","title":"Blueprint Medicines Corporation6月20日成交额为5.77亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545109774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545109774?lang=zh_cn&edition=full","pubTime":"2025-06-21 09:23","pubTimestamp":1750469005,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日，Blueprint Medicines Corporation成交额为5.77亿美元，成交额较昨日增加27.29%，当日成交量为450.62万股。Blueprint Medicines Corporation于2025年6月20日涨0.06%，报128.2美元，该股过去5个交易日跌0.01%，年初至今涨46.98%，过去60日涨37.73%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621092333a4b588c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621092333a4b588c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2544904182","title":"Blueprint Medicines Corporation6月18日成交额为4.54亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544904182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544904182?lang=zh_cn&edition=full","pubTime":"2025-06-19 09:23","pubTimestamp":1750296222,"startTime":"0","endTime":"0","summary":"美东时间2025年6月18日，Blueprint Medicines Corporation成交额为4.54亿美元，成交额较昨日增加5.57%，当日成交量为354.03万股。Blueprint Medicines Corporation于2025年6月18日跌0.09%，报128.12美元，该股过去5个交易日涨0.13%，年初至今涨46.89%，过去60日涨34.48%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619092349a4b18a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619092349a4b18a5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BPMC","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2544898096","title":"Blueprint Medicines Corporation6月16日成交额为6.59亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544898096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544898096?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:24","pubTimestamp":1750123440,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日，Blueprint Medicines Corporation成交额为6.59亿美元，成交额较昨日增加8.75%，当日成交量为514.82万股。Blueprint Medicines Corporation于2025年6月16日涨0.23%，报128.25美元，该股过去5个交易日涨0.22%，年初至今涨47.04%，过去60日涨44.96%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092411a70d2e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092411a70d2e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BPMC","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2543765158","title":"Blueprint Medicines Corporation6月13日成交额为6.06亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543765158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543765158?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:24","pubTimestamp":1749864240,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日，Blueprint Medicines Corporation成交额为6.06亿美元，成交额较昨日增加1.72%，当日成交量为473.18万股。Blueprint Medicines Corporation于2025年6月13日跌0.19%，报127.96美元，该股过去5个交易日涨0.09%，年初至今涨46.71%，过去60日涨41.42%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614092403a7088a5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614092403a7088a5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC","BK4505","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2542059554","title":"Blueprint Medicines Corporation6月11日成交额为4.90亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542059554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542059554?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:23","pubTimestamp":1749691437,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，Blueprint Medicines Corporation成交额为4.90亿美元，成交额较昨日减少14.19%，当日成交量为382.68万股。Blueprint Medicines Corporation于2025年6月11日跌0.02%，报127.95美元，该股过去5个交易日跌0.12%，年初至今涨46.7%，过去60日涨38.86%。该公司在其研发管线中还有多种其他药物候选者，如 BLU-808、BLU-222、BLU-956 等，旨在治疗包括 SM 和慢性荨麻疹、乳腺癌及其他实体肿瘤在内的肥大细胞疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092402a7045a9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092402a7045a9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC","BK4505","BK4139","LU0053671581.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blueprintmedicines.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0126},{"period":"1year","weight":0.3616},{"period":"ytd","weight":0.4843}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"蓝图医药公司于2008年10月14日在特拉华州成立，是一家生物制药公司，专注于改善患者的异常活化蛋白激酶基因组驱动的疾病定义的生命。该公司的做法是系统性和可重复鉴定激酶是基因组疾病定义驱动器和手艺的候选药物与治疗窗户，提供显著和持久的临床反应的患者。该公司正致力于几乎所有的努力研发，最初的市场开发，提高资本。该公司是受一些风险相似的其他早期阶段的公司，包括关键个人的依赖;需要开发商业上可行的药物;其他公司，其中有许多是更大和更好的资本竞争;并需要获得足够的额外资金，其药物的开发提供资金。如果公司无法筹集资金需要时或有吸引力的条件，这将被迫推迟，减少，消除或超出许可它的某些研究和开发项目或今后的商业化努力。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.021421},{"month":2,"riseRate":0.6,"avgChangeRate":-0.00304},{"month":3,"riseRate":0.7,"avgChangeRate":0.03296},{"month":4,"riseRate":0.4,"avgChangeRate":-0.01942},{"month":5,"riseRate":0.727273,"avgChangeRate":0.094205},{"month":6,"riseRate":0.636364,"avgChangeRate":0.080061},{"month":7,"riseRate":0.727273,"avgChangeRate":0.013767},{"month":8,"riseRate":0.7,"avgChangeRate":0.055409},{"month":9,"riseRate":0.6,"avgChangeRate":0.028138},{"month":10,"riseRate":0.4,"avgChangeRate":-0.027795},{"month":11,"riseRate":0.6,"avgChangeRate":0.051662},{"month":12,"riseRate":0.5,"avgChangeRate":0.031046}],"exchange":"NASDAQ","name":"Blueprint Medicines Corporation","nameEN":"Blueprint Medicines"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Blueprint Medicines Corporation(BPMC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Blueprint Medicines Corporation,BPMC,Blueprint Medicines Corporation股票,Blueprint Medicines Corporation股票老虎,Blueprint Medicines Corporation股票老虎国际,Blueprint Medicines Corporation行情,Blueprint Medicines Corporation股票行情,Blueprint Medicines Corporation股价,Blueprint Medicines Corporation股市,Blueprint Medicines Corporation股票价格,Blueprint Medicines Corporation股票交易,Blueprint Medicines Corporation股票购买,Blueprint Medicines Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Blueprint Medicines Corporation(BPMC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}